Interestingly, magnolol exhibited a synergistic effect, where it killed melanoma cells at much lower doses of dabrafenib and docetaxel than those currently used in the clinics.25 Combined treatment also led to downregulation of the MAPK‐ERK and PI3K/Akt pathways. Here, AKT1 is linked to melanoma.